Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
How Trump’s policies could reverse decades of progress in Latin America’s HIV response
It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government ...
Rolling Out12h
Drug abuse doubles your HIV risk, doctors warn
Understand how drug use increases HIV risk and learn about prevention strategies that save lives. Medical experts explain ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Marketplace7h
The foreign aid freeze is affecting lifesaving HIV/AIDS treatment
The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...
Rolling Out1d
Silent warning signs of HIV you’re likely dismissing
From persistent fevers to unexplained weight loss, discover the subtle HIV symptoms doctors say you shouldn't ignore, ...
Disconnected helplines, undiagnosed HIV cases and unfinished classrooms: Ukraine counts the costs of USAID suspension
Some 400 calls for help went unanswered when the helpline at Ukraine’s Veteran Hub went silent for a week after key funding ...
Stigma, Unequal Access and an Aging Population: Challenges to HIV Care and Prevention
Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...
Monthly Prescribing Reference3h
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The Food and Drug Administration (FDA) has accepted under Priority Review the New Drug Application (NDA) for lenacapavir, a long-acting HIV-1 capsid inhibitor, for the prevention of HIV as ...